Case 29 – update 3

We are discussing a chap in his 40s with angina, previous transient ischaemic attack and polycythaemia. Because of his smoking history and relative alcohol excess we were wondering about secondary polycythaemia. He has had some fluids and his indices remain the same. The vascular events could be related to smoking but teamhaem were concerned about polycythaemia vera which is also associated with arterial and venous thrombosis.  with this in mind we asked about particular features:

  • Night sweats
  • Weight loss, lethargy
  • Splenomegaly
  • Aquagenic pruritis
  • Thrombosis (venous/arterial) and bleeding
  • Headache/visual disturbance
  • Dizziness
  • Erythromelalgia

There is no family history to point towards a genetic cause of polycythaemia and no recreational erythropoietin use.  Despite the indicators pointing towards secondary polycythaemia we felt it was important to look for a mutation in the JAK2 (Janus Kinase2) gene. The V617F (change of valine to phenylalanine at the 617 position) is found in about 95% of patients with polycythaemia and mutations in exon 12 are found in another 2-4%.

Results have been expedited and he is found to harbour the JAK2 V617F mutation. Epo levels are low.  Post one venesection his Hb is 19.6g/L and HCT 0.58.


  • Does this mean he has polycythaemia vera? Which guidelines are you using?
  • Are you going to do a bone marrow?
  • Do you tell him he has a malignancy?
  • He has had one venesection – what do you do next?

Please reply on Twitter and always include #teamhaem to allow others to follow your comments. Please join in the debate and learn about haematological problems along the way. The case will continue to  evolve over the coming week so keep checking #teamhaem for more information.

Please note – all cases on TeamHaem are entirely fictional to protect patient confidentiality.

TeamHaem are not a position of authority.  It is an educational platform to allow discussion and learning.

About TeamHaem

Online education and discussion about all things haematological
This entry was posted in Myeloproliferative neoplasm, Related to other specialities and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s